Announced
ICON BIOSCIENCE INC / EYEPOINT PHARMACEUTICALS INC / Acquisition / Private / £70m
Synopsis
US$100 million acquisition of Icon Bioscience, Inc., a specialty biopharmaceutical company.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.